Jay Caplan

Company: Fractyl Therapeutics

Job title: Founder & President

Seminars:

Panel Discussion: Genetic & Phenotypic Based Approaches to Further Precision Medicine to More Effectively Combat Obesity 4:40 pm

Identifying the key biomarkers and patient characteristics that predict treatment response and adverse events to different obesity medications and interventions. Exploring the ethical and social implications of personalized obesity treatment, including access, equity, and the potential for disparities in care. Developing strategies for integrating personalized medicine approaches into routine clinical practice, including the development of…Read more

day: Day One

Why Physiologically-Regulated GLP-1 May Improve the Efficacy and Tolerability of Weight Loss Therapeutics 11:00 am

Mimicking the physiologic secretion profile of GLP-1 to provide receptor agonism when it is needed, for improved efficacy and tolerability Targeting individual patient needs by developing a platform for several multi-agonist therapies Reducing treatment burden with a one-time, life-long therapyRead more

day: Day One